Mandy S. Lai
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer.
Journal: Alimentary pharmacology & therapeutics
Published: April 01, 2025
Increased risk of HCC in HBeAg-negative indeterminate phase compared with HBeAg-negative chronic infection.
Journal: Hepatology (Baltimore, Md.)
Published: November 24, 2024
Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong Kong.
Journal: JHEP reports : innovation in hepatology
Published: October 03, 2024
Histological severity, clinical outcomes and impact of antiviral treatment in indeterminate phase of chronic hepatitis B: A systematic review and meta-analysis.
Journal: Journal of hepatology
Published: May 29, 2024
Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B.
Journal: Journal of hepatology
Published: September 21, 2023
Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes.
Journal: JAMA network open
Published: April 27, 2023
Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: February 12, 2023
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir.
Journal: JAMA network open
Published: December 06, 2022
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 12, 2022
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss.
Journal: Journal of hepatology
Published: August 10, 2022
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.
Journal: Alimentary pharmacology & therapeutics
Published: August 08, 2022
Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 09, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026